Valor Management LLC

Institutional investor · Portfolio as of Q4 2024

Q4 2024 biggest moves
  • HRMYHRMY

    Harmony Biosciences

    Cut 41%

    now 91% of portfolio

  • ALABALAB

    Astera Labs

    Sold out

    was 4.9% of portfolio

  • BWAYBWAY

    BrainsWay

    New

    8.0% of portfolio

3 changes in all

Top Holdings4 positions

Checking export access…
Activity:
HRMY

Harmony Biosciences Holdings, Inc.

6.6M$227.7M91.4%$42.64-19.30%
13 qtrssince 2021-Q4
Decreased
0
BWAY
BWAY
ADR

BrainsWay Ltd.

2.1M$19.8M8.0%$4.720.00%
1 qtr
New
91
SONDQ
SONDQDelisted

SONDER HOLDINGS INC

476,321$1.5M0.6%——
6 qtrssince 2023-Q3
Unchanged
0
BIOA

BioAge Labs, Inc.

13,105$75,8780.0%$20.80-72.16%
2 qtrssince 2024-Q3
Unchanged
0
$249.2M
AUM
4
Positions
Q4 2024
Filing
HI rating · 1.5/5
Quarterly 13F Value Change
Reported 13F value ($M)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2023-Q3$371,545,052-7.49285440942%
2023-Q4$363,964,641-2.04024006219%
2024-Q1$479,566,64231.7618768357%
2024-Q2$454,745,175-5.17581183222%
2024-Q3$474,598,9284.3659073458%
2024-Q4$249,155,410-47.5019020692%
Activity profile
$ moved · Q4'24
New8%Increased0%Decreased84%Exited9%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.1 years
<1Q25%1-4Q25%1-2Y25%2Y+25%

Valor Management LLC manages $249.2M across 4 positions as of Q4 2024. Top holdings: HRMY (91.4%), BWAY (8.0%), SONDQ (0.6%). Fund DNA: Concentrated Value. HoldingsIntel Score: 1.5/5.0.

Top holdings by portfolio weight

Total AUM$249M
HRMY91.40%
BWAY7.96%
SONDQ0.61%
BIOA0.03%
ALAB0.00%

Portfolio allocation by GICS sector

Sectors2
Healthcare99.39%
Consumer Cyclical0.61%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Healthcare
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(1.5 / 5.0)
Holdings P&L18
Conviction71
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Top Losers

Checking access…

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Photo credits

Photo:“Warren Buffett at the 2015 SelectUSA Investment Summit”by USA International Trade Administration, cropped,public domainvia Wikimedia Commons

Photo:Leopold Aschenbrenner

Photo:“Cathie Wood ARK Invest Photo”by Caroline Wood, cropped,CC BY-SA 4.0via Wikimedia Commons

Photo:“Valeant Pharmaceuticals' Business Model (headshot)”by Senate Democrats, cropped,CC BY 2.0via Wikimedia Commons

Photo:Harlem Children's Zone

Photo:Mohnish Pabrai

Photo:“Peter Thiel on March 5 2026”by Kantei (The Prime Minister Office of Japan), cropped,CC BY 4.0via Wikimedia Commons

Photo:Charlotte FC

Photo:Ray Dalio

Photo:Himalaya Capital

Photo:Jonathan Kozowyk, Robin Hood

Photo:“Brad Gerstner at the White House 2025 (54581192563)”by The White House, cropped,public domainvia Wikimedia Commons

Photo:SuperReturn North America

Photo:Liz Linder, Harvard Kennedy School

Photo:Oaktree Capital Management

Photo:The Everglades Foundation

Photo:George Soros

Photo:Benjamin Meaker, Point72

Photo:Fundsmith

Photo:“Kenneth C. Griffin photo”by Paul Elledge, cropped,CC BY-SA 4.0via Wikimedia Commons

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used